Tricida, Inc. (TCDA) Covered Calls

Tricida, Inc., a pharmaceutical company, focuses on the development and commercialization of its drug candidate, TRC101, a non-absorbed, orally-administered polymer designed as a potential treatment for metabolic acidosis in patients with chronic kidney disease (CKD). The company has completed a Phase 3, double-blind, placebo-controlled trial of TRC101 in patients with CKD and metabolic acidosis. Tricida, Inc. was founded in 2013 and is headquartered in South San Francisco, California.

You can sell covered calls on Tricida, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for TCDA (prices last updated Fri 4:16 PM ET):

Tricida, Inc. (TCDA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
0.21 +0.01 0.22 0.22 27.9M - 0.0
Covered Calls For Tricida, Inc. (TCDA)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Dec 16 2.5 0.00 0.22 0.0% 0.0%
Jan 20 2.5 0.00 0.22 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial